(Report ID: 96036) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,646 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 26 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 96036 | Apr, 11, 2006 | 53 | Female |
List of drugs the patient takes:
| Drug |
Glucophage |
Aspirin |
Levemir |
List of drug interactions, adverse side effects / events the patient has:
Results from eHealthMe: 26 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Hypoglycaemic Coma | 1 (3.85%) |
2) Top drug interactions, adverse side effects reported for the past 12 months:Death: 0 Cancer: 0
| Name | Count (% of total reports) |
1 | Acute Myocardial Infarction | 1 (50.00%) |
2 | Urinary Tract Infection | 1 (50.00%) |
3 | Hyperglycaemia | 1 (50.00%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Byetta | 4 |
2 | Metformin Hcl | 3 |
3 | Glipizide | 2 |
4 | Tricor | 1 |
5 | Avapro | 1 |
6 | Novolog | 1 |
7 | Magnesium Sulfate | 1 |
8 | Lantus | 1 |
4) Top drug interactions, adverse side effects reported of all time:Death: 2 (7.69% of total reports) Cancer: 1 (3.85% of total reports)
| Name | Count (% of total reports) |
1 | Constipation | 7 (26.92%) |
2 | Hypoglycaemia | 6 (23.08%) |
3 | Drug Interaction | 4 (15.38%) |
4 | Hyperglycaemia | 4 (15.38%) |
5 | Nausea | 3 (11.54%) |
6 | Urinary Tract Infection | 3 (11.54%) |
7 | Fatigue | 3 (11.54%) |
8 | Chest Pain | 3 (11.54%) |
9 | Injection Site Bruising | 3 (11.54%) |
10 | Blood Glucose Increased | 3 (11.54%) |
5) Top co-used drugs drugs reported of all time:
| Name | Count |
1 | Metformin Hcl | 16 |
2 | Lantus | 9 |
3 | Byetta | 8 |
4 | Lisinopril | 6 |
5 | Spironolactone | 6 |
6 | Bumetanide | 6 |
7 | Lansoprazole | 5 |
8 | Lipitor | 4 |
9 | Amiodarone Hcl | 4 |
10 | Amitriptyline Hcl | 3 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
Cymbalta (Lilly) - EQ 20MG BASE for Depression (Nov, 21, 2008)
|
Vicodin Es (Abbott) - 750MG;7.5MG for Toothaches (Nov, 21, 2008)
|
Vicodin Es (Abbott) - 750MG;7.5MG for Toothaches (Nov, 21, 2008)
|
Lyrica (Pfizer) - 100MG for Back Pain - Low (Nov, 21, 2008)
|
Sodium Bicarbonate (Hospira) - 0.9MEQ... for Heartburn (Nov, 21, 2008)
|
Side effects comparison of Lipitor (Pfizer) - EQ 20MG BASE (Nov, 21, 2008)
|
Lipitor (Pfizer) - EQ 20MG BASE for Cholesterol (Nov, 21, 2008)
|
Lipitor (Pfizer) - EQ 20MG BASE for Cholesterol (Nov, 21, 2008)
|
Digoxin (Roxane) - 0.05MG/ML for Heart Condition (Nov, 21, 2008)
|
Digoxin (Roxane) - 0.05MG/ML for Heart Condition (Nov, 21, 2008)
|
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|